GSK Requested Changes Sample Clauses

GSK Requested Changes. GSK shall be entitled to change the Specifications for a Product from time to time, and Draxis shall make all revisions to the Specifications requested by GSK, in accordance with the Change Control Operating Procedures set forth on Schedule 4.3 to this Agreement. GSK retains the right and responsibility for final approval of the Specifications for the Products. Except to the extent provided in Section 4.2(c)(ii) or Section 4.2(d) below, GSK shall pay Draxis the amounts incurred in implementing a change to the Specifications requested by GSK under this Section 4.2(a), as determined in accordance with the Change Control Operating Procedures and the Schedule of Rates set forth on Schedule 4.2(a) to this Agreement. Schedule 4.2 shall be developed jointly, and mutually agreed to, by GSK and Draxis within ninety (90) days of the execution of this Agreement and shall be promptly thereafter attached hereto. For all changes to the Specifications requested by GSK pursuant to this Section 4.2(a), GSK shall, in its discretion, either (i) perform, or arrange for the performance of, all development work in connection therewith or (ii) have Draxis perform such development work at the Facility. GSK shall reimburse Draxis for its actual costs incurred with GSK’s prior approval in implementing a change to the Specifications requested by GSK under this Section 4.2(a); and Draxis must provide such documentation of its costs as may be reasonably requested by GSK. Draxis agrees to use commercially reasonable efforts to minimize its costs associated with any Specification change. At the request of GSK, Draxis shall evaluate the estimated costs and timing of potential revisions to the Specifications.